📰 Visiox Pharma News
Page 2 - Visiox Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Visiox Pharma. Real-time updates on events, politics, business and more.
October 13, 2022
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
October 6, 2022
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
September 26, 2022
SPARC focuses on discovery and research of novel drugs prioritised in three therapeutic areas i.e. oncology, neurology and immunology. According to the company, during FY22, SPARC raised $148 million to complete the ongoing clinical studies.
August 3, 2022
/PRNewswire/ -- Visiox Pharma, LLC, a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to...
August 3, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 15, 2022
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic...
May 17, 2022
/PRNewswire/ -- Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic...
December 8, 2021
Sun Pharma Research inks licensing pact with Visiox Pharma for ophthalmic products
December 8, 2021
Licenses development and commercialisation rights of PDP-716 and SDN-037 to Visiox Pharma